- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03832322
Adenoma Miss Rate With Water Exchange vs Carbon Dioxide Colonoscopy
April 11, 2023 updated by: Chi-Liang Cheng, Evergreen General Hospital, Taiwan
Water Exchange Colonoscopy Decreased Adenoma Miss Rates in the Right and Proximal Colon: An Observational Study Using A Tandem Colonoscopy Approach
This was an observational study comparing consecutive group of WE and CO2 insufflation in terms of right and proximal colon AMR by tandem colonoscopy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This was a prospective observational study to assess how WE colonoscopy would fit into clinical and research practices.
We first observed whether optimal WE colonoscopy decreased the AMR in the right and proximal colon in a tandem approach.
If WE did lower the AMR as compared with data in the literature, a randomized RCT deserves to be studied.
For the calculation of sample size in the upcoming RCT, the AMR in the CO2 group would be collected.
The differences of the AMRs in the right and proximal colon determined by tandem colonoscopy using WE or CO2 insufflation would then be compared.
Study Type
Observational
Enrollment (Actual)
176
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taoyuan, Taiwan, 320
- Evergreen General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
86 eligible patients completed first-pass colonoscopy with WE insertion and CO2 withdrawal, followed by back-to-back second-pass colonoscopy with CO2 insertion and CO2 withdrawal during July 9 to Oct 12, 2018; Another 86 eligible patient completed first-pass colonoscopy with CO2 insertion and CO2 withdrawal, followed by back-to-back second-pass colonoscopy with CO2 insertion and CO2 withdrawal during Oct 15 to Nov 21, 2018.
Description
Inclusion Criteria:
- Consecutive patients aged 20 years or older undergoing colonoscopy for screening and surveillance indications were considered for enrollment.
Exclusion Criteria:
- familial adenomatous polyposis and hereditary non-polyposis CRC syndrome, personal history of inflammatory bowel disease, previous colonic resection, inability to achieve cecal intubation, obstructive lesions of the colon, poor colon preparation, inability to completely remove a polyp, gastrointestinal bleeding, allergy to fentanyl or midazolam, American Society of Anesthesiology classification of physical status grade 3 or higher, mental retardation, pregnancy, and refusal to provide a written informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Water exchange colonoscopy
During the insertion phase of the first-pass colonoscopy, water exchange (WE) method was used.
WE entailed the infusion of water to open the lumen and sequentially suction of water.
When the cecum was reached and after most of the water was suctioned to collapse the cecal lumen, CO2 was opened during the withdrawal phase of the first-pass colonoscopy.
After the first complete withdrawal of the colonoscope, a second colonoscopic examination aided by CO2 insufflation during insertion and withdrawal was performed by the same endoscopist.
The colonoscope was reinserted into the cecum as quickly as possible, and the entire colon was re-examined.
Polyp resection was carried out during insertion and withdrawal of the first- and second-pass examinations.
|
During back-to-back colonoscopy, the first examination was completed with water exchange during insertion and CO2 insufflation during withdrawal.
The second examination was completed with CO2 insufflation during both the insertion and withdrawal.
During back-to-back colonoscopy, the first examination was completed with CO2 insufflation during both the insertion and withdrawal.
The second examination was also completed with CO2 insufflation during both the insertion and withdrawal.
|
CO2 insufflation colonoscopy
During the first-pass colonoscopy, the procedure was performed in the usual fashion, with minimal CO2 insufflation to aid insertion.
Cleaning of colon was predominantly performed during withdrawal.
After the first complete withdrawal of the colonoscope, a second colonoscopic examination aided by CO2 insufflation during insertion and withdrawal was performed by the same endoscopist.
The colonoscope was reinserted into the cecum as quickly as possible, and the entire colon was re-examined.
Polyp resection was carried out during insertion and withdrawal of the first- and second-pass examinations.
|
During back-to-back colonoscopy, the first examination was completed with CO2 insufflation during both the insertion and withdrawal.
The second examination was also completed with CO2 insufflation during both the insertion and withdrawal.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Overall Detected Adenomas Missed During the First Right-Colon Colonoscopy
Time Frame: During procedure, approximately 1.5 hours
|
Right-colon (cecum, A-colon, hepatic flexure) adenomas detected on the second-pass examination were used for the calculation of adenoma miss.
Adenoma miss rate was calculated as the number of adenomas missed in the first colonoscopy divided by the total number of adenomas detected during both the first and second colonoscopies.
|
During procedure, approximately 1.5 hours
|
Percentage of Overall Detected Adenomas Missed During the First Proximal-Colon Colonoscopy
Time Frame: During procedure, approximately 1.5 hours
|
Proximal-colon (cecum, A-colon, hepatic flexure, T-colon) adenomas detected on the second-pass examination were used for the calculation of adenoma miss.
Adenoma miss rate was calculated as the number of adenomas missed in the first colonoscopy divided by the total number of adenomas detected during both the first and second colonoscopies.
|
During procedure, approximately 1.5 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 9, 2018
Primary Completion (Actual)
November 28, 2018
Study Completion (Actual)
November 28, 2018
Study Registration Dates
First Submitted
February 2, 2019
First Submitted That Met QC Criteria
February 4, 2019
First Posted (Actual)
February 6, 2019
Study Record Updates
Last Update Posted (Actual)
April 12, 2023
Last Update Submitted That Met QC Criteria
April 11, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EGH-2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colonic Adenoma
-
Norwegian Department of Health and Social AffairsUniversity of Oslo; Oslo University Hospital; Beth Israel Deaconess Medical Center and other collaboratorsUnknownColonic Polyp | Adenoma Colon | Colonic Adenoma
-
Fondazione Poliambulanza Istituto OspedalieroCompletedAdenoma Colon | Colonic AdenomaItaly
-
Dalin Tzu Chi General HospitalCompletedColonic Polyp | Colonic AdenomaTaiwan
-
Chinese University of Hong KongCompleted
-
Société Française d'Endoscopie DigestiveCompletedColonic Polyp | Colonoscopy | Colonic AdenomaFrance
-
Air Force Military Medical University, ChinaCompletedBowel Preparation | Colonic AdenomaChina
-
South Tyneside and Sunderland NHS Foundation TrustMedtronic; Newcastle University; North Wales Organisation for Randomised Trials...CompletedColonic Polyp | Colorectal Adenoma | Colorectal Polyp | Colorectal SSA | Colorectal Adenomatous Polyp | Sessile Serrated Adenoma | Sessile Colonic PolypUnited Kingdom
-
King's College Hospital NHS TrustMedtronic; National Institute for Health Research, United KingdomRecruitingColonic Polyp | Colo-rectal Cancer | Colonic AdenomaUnited Kingdom
-
Changi General HospitalCompleted
-
Western Sydney Local Health DistrictCompleted
Clinical Trials on Water exchange colonoscopy
-
Air Force Military Medical University, ChinaCompleted
-
University of California, DavisCompletedColon Cancer | Hyperplastic Polyp | Tubular AdenomaUnited States
-
Sorlandet Hospital HFErasmus Medical Center; South-Eastern Norway Regional Health Authority; Maria...CompletedPain | Colorectal Cancer | Colorectal Polyps | Colorectal AdenomasNorway, Poland
-
Dalin Tzu Chi General HospitalCompletedColonoscopy | Intubation Time | Cap-assisted ColonoscopyTaiwan
-
Dalin Tzu Chi General HospitalRecruitingColonoscopy | Colon AdenomaUnited States, Taiwan
-
Presidio Ospedaliero Santa BarbaraCompletedAbdominal PainUnited States, Czech Republic, Italy
-
East Bay Institute for Research and EducationCompleted
-
VA Office of Research and DevelopmentCompletedColorectal NeoplasmsUnited States
-
Dalin Tzu Chi General HospitalCompletedAdenomaTaiwan, United States
-
Dalin Tzu Chi General HospitalCompleted